期刊
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
卷 27, 期 5, 页码 957-974出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2013.07.002
关键词
Leiomyosarcoma; Chemotherapy; Targeted therapy; Prognostic factors; Uterine leiomyosarcoma
资金
- Spanish Society of Medical Oncology
- Driscoll Family Leiomyosarcoma Research Fund
This article presents an overview of the current literature about the biology, pathology, and the clinical management of leiomyosarcoma. In addition, the article emphasizes and discusses the current systemic treatment options available for patients with leiomyosarcoma, which range from cytotoxic chemotherapy to target therapies. Particular leiomyosarcoma subtypes, such as uterine leiomyosarcoma and inferior vena cava leiomyosarcoma, are discussed separately.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据